Apelin Alleviated Endothelial‐To‐Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy
The FASEB Journal · 2025
DOI: 10.1096/fj.202500489r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Chunmeng Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Apelin, Endothelial Cells, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Endothelial‐to‐mesenchymal transition (EndMT) is a critical pathophysiological process in fibrosis which is associated with large conductance calcium‐activated potassium (BKCa) channels. Apelin, an adipokine, was reported to alleviate glomerular EndMT mainly caused by hyperglycemia in diabetic nephropathy (DN) and related to BKCa. Therefore, it is supposed that apelin reduced glomerular EndMT by increasing BKCa in glomerular endothelial cells (GECs). The results showed that apelin inhibited diabetic glomerular fibrosis and EndMT in vivo and in vitro, such as increasing endothelial markers CD31, VE‐Cadherin and decreasing mesenchymal α‐SMA, Desmin, which were reversed after specific APJ knockout in endothelial cells. Meanwhile, apelin increased BKCa, and the suppressed effect of apelin on Wnt/β‐Catenin signaling pathway was canceled after BKCa was inhibited by Iberiotoxin (IBTX) in GECs under high glucose condition. Furthermore, IBTX also inhibited SP1 translocation into nuclei, followed by increased expression of DKK1 in apelin treated GECs under high glucose condition. In conclusion, apelin/APJ alleviated EndMT in diabetic glomerular fibrosis by inhibiting the Wnt/β‐Catenin pathway, which was mediated by BKCa activated SP1, leading to an increased expression of DKK1 in GECs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
- Diabetic Cardiac and Renal Complications, Laboratory for Clinical Medicine, Capital Medical University, Beijing, People's Republic of China.
- Department of Pathology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
- Department of Pathology, Beijing You'an Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
- Beijing Institute of Hepatology, Beijing You'an Hospital, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Chunmeng Fan, Mingcong Huang, Xiang Zheng, Xiangjun Zeng
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Fan, C., Liu, Y., Chang, J., Huang, M., Gao, Z., Wang, H., Zheng, X., Li, M., Xu, J., Yin, J., & Zeng, X. (2025). Apelin Alleviated Endothelial‐To‐Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy. The FASEB Journal. https://doi.org/10.1096/fj.202500489r
Vancouver
Fan C, Liu Y, Chang J, Huang M, Gao Z, Wang H, et al. Apelin Alleviated Endothelial‐To‐Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy. The FASEB Journal. 2025. doi:10.1096/fj.202500489r
BibTeX
@article{Fan2025,
author = {Fan, Chunmeng and Liu, Yu and Chang, Jing and Huang, Mingcong and Gao, Zihao and Wang, Huade and Zheng, Xiang and Li, Menghe and Xu, Jialiang and Yin, Jiming and Zeng, Xiangjun},
title = {Apelin Alleviated Endothelial‐To‐Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500489r}
}
EUVIMED